Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative

NCT05153343 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Myeloproliferative Neoplasm (MPN)
Myelofibrosis，MF

Interventions

DRUG: flonoltinib 25mg
DRUG: flonoltinib 100mg
DRUG: flonoltinib 150mg
DRUG: flonoltinib 225mg
DRUG: flonoltinib 50mg

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd